Crain's New York2d
Mount Sinai and Memorial Sloan Kettering advance AI tool for new cancer treatment
Researchers at Mount Sinai and Memorial Sloan Kettering believe they’ve made a breakthrough in a new form of cancer treatment ...
Health Rounds: Eligibility criteria limits minority patient access to precision cancer drugs
Eligibility for treatment with the latest cancer drugs is often determined by genetic mutations in tumors, criteria that ...
Why New Precision Oncology Cancer Treatments Benefit Patients of Some Ancestries More Than Others
Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ...
Novel brain mechanism links neurotransmitters to circadian gene expression
A collaborative effort between Mount Sinai and Memorial Sloan Kettering Cancer Center has shed valuable light on how ...
Armed robbery in Revesby4d
AI Tool Democratizes Cancer Immunotherapy Access
Researchers at The Tisch Cancer Institute at Mount Sinai, in collaboration with Memorial Sloan Kettering Cancer Center (MSK), ...
Renal & Urology News1d
Testosterone Therapy May Not Up Prostate Cancer Recurrence Risk
Research suggests the benefits of testosterone therapy after prostate cancer surgery in select men may outweigh risks.
Becker's Hospital Review4d
Mount Sinai, MSK researchers create AI tool to predict immunotherapy outcomes
Determining which cancer patients are a good candidate for immune checkpoint inhibitors can be a challenge, but researchers at Mount Sinai and Memorial Sloan Kettering Cancer Center have developed a ...